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In nonhuman primates, simian varicella virus (SV V) causes a natural disease which is clinically similar to human
varicella-zoster virus (VZV) infections. The SV V and VZV genomes are similar in size and structure and share extensive DNA
homology. This report presents the complete DNA sequence of the SV V genome. SV V DNA is 124,138 bp in size, 746 bp
shorter than VZV DNA, and 40.4% G 1 C. The viral genome includes a 104,104-bp unique long component bracketed by 8-bp
inverted repeat sequences and a short component composed of a 4904-bp unique short region bracketed by 7557-bp
inverted repeat sequences. A total of 69 distinct SV V open reading frames (ORFs) were identified, including three that are
duplicated within the inverted repeats of the short component. Each of the SV V ORFs shares extensive homology to a
corresponding VZV gene. The only major difference between SV V and VZV DNA occurs at the leftward terminus. SV V lacks
a VZV ORF 2 homolog. In addition, SV V encodes an 882-bp ORF A that is absent in VZV, but has homology to the SV V and
VZV ORF 4. The results of this study confirm the relatedness of SV V and VZV and provide further support for simian varicella
as a model to investigate VZV pathogenesis and latency. © 2001 Academic Press
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Varicella-zoster virus (VZV, Human herpesvirus 3)
causes varicella (chickenpox), a common disease of
childhood. Following primary infection, VZV establishes
latent infection in neural ganglia. Later in life, the virus
may reactivate, resulting in herpes zoster (shingles).
While VZV infections are often relatively benign, they may
be severe, causing debilitating and life-threatening dis-
ease, especially in immunosuppressed individuals. Un-
fortunately, studies to investigate VZV pathogenesis and
latency and to evaluate antiviral agents and vaccines are
hampered because VZV does not cause disease in ex-
perimental animals.
Simian varicella virus (SVV, Cercopithecus herpesvirus
7) causes a natural varicella-like disease in nonhuman
primates (Oakes and d’Offay, 1988). Simian varicella
epizootics occur sporadically in facilities housing mon-
keys. Similar to VZV, SV V establishes latent infection in
the host (Mahalingam et al., 1991) and may reactivate to
cause secondary disease. The antigenic and genetic
relatedness between SV V and VZV (Fletcher and Gray,
1992; Gray and Oakes, 1984; Pumphrey and Gray, 1992)
and the clinical and pathogenic similarities between sim-
ian and human varicella make SVV infection of nonhu-
man primates a valuable animal model to investigate
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123varicella pathogenesis and antiviral strategies (Soike,
1992).
The SVV and VZV genomes are similar in size and
structure and are colinear with respect to gene organi-
zation (Gray et al., 1992; Clarke et al., 1992; Pumphrey
and Gray, 1992). The DNA sequence of the entire
124.8-kb VZV double-stranded DNA genome has been
determined (Davison and Scott, 1986). The VZV DNA
includes a 19.9-kb short (S) component covalently linked
to a 105.0-kb long component (L). The S component
consists of a 5.2-kb unique short (US) sequence brack-
eted by 7.3-kb internal and terminal inverted repeat se-
quences (IRS and TRS). Likewise, the L component in-
cludes 88-bp internal and terminal inverted repeat se-
quences (IRL and TRL), which bracket the 104.8-kb
unique long (UL) component. Restriction endonuclease
mapping and electron microscopic analysis of SVV DNA
indicate that the SVV genome is approximately 121–125
kb in size and has a similar structure as VZV DNA (Gray
et al., 1992; Clarke et al., 1992). DNA sequence analysis
f the SVV US and IRS has confirmed the genetic relat-
dness of SVV and VZV (Fletcher and Gray, 1993; Gray et
l., 1995).
In this study, we present the complete DNA sequence
f the SVV genome. The coding capacity and genetic
ontent of SVV DNA is analyzed and compared to the
ZV genome. The SVV DNA sequence provides a foun-
ation for further investigation of the molecular basis of
aricella pathogenesis and latency and for development
f antiviral agents and vaccines.
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124 GRAY ET AL.RESULTS AND DISCUSSION
eneral features of SVV DNA: Size, structure, and
uanine 1 cytosine percentage (G 1 C%)
The entire SVV genome sequence was determined by
directed sequencing approach utilizing overlapping
VV DNA BamHI and EcoRI RE fragments (Gray et al.,
992). The total sequence data included approximately
3 106 nucleotides derived from both DNA strands. The
esults confirm that the SVV genome includes L and S
omponents, each composed of a unique sequence (UL
nd US) bracketed by internal and terminal inverted
epeat sequences (IRL/TRL and IRS/TRS) (Fig. 1).
The SVV genome is 124,138 bp in size, similar to the
21–125 kb size originally estimated by restriction endo-
uclease analysis and pulsed-field gel electrophoresis
Gray et al., 1992; Clarke et al., 1992). The SVV genome is
46 bp smaller than the VZV genome, making SVV DNA
he smallest herpesvirus genome sequenced to date
Table 1). Most of this size differential is attributed to the
04,120-bp SVV L component which is 893 bp shorter
han the VZV L component. The SVV UL component
104,104 bp) is bracketed by an 8-bp inverted repeat
equence (GGCCGGGG) compared to the 88-bp VZV IRL
nd TRL.
The SVV and VZV S components are similar in size.
FIG. 1. Gene map of the SV V genome. The SV V genome consists o
vertical lines) and a short unique region (US) bordered by internal an
horizontal arrows. Gene 33.5 is not a distinct ORF, but represents a po
VZV orf 33.5 (Garcia-Valcarcel et al., 1997). The reiterated sequences (R
replication (oriS) are designated by open boxes. The vertical lines abohe total length of the SVV S component (20,018 bp) is
nly 147 bp longer than the VZV S component. The SVVRS/TRS is slightly expanded compared to the VZV IRS/
RS (7557 vs 7319 bp), while the SVV US is slightly
horter in length than the VZV US (4904 vs 5232 bp).
The calculated size of SVV DNA does not take into
ccount the possibility of unpaired nucleotides at the
enome termini. The VZV and herpes simplex virus type
(HSV-1) genomes include a single unpaired nucleotide
t each 39 terminus (Davison, 1984; Mocarski and Roiz-
an, 1982). The presence of unpaired terminal nucleo-
ides facilitates circularization of the VZV and HSV-1
enomes during viral replication. Since circular SVV
NA is detected within infected cells, it is expected that
ique long (UL) component bracketed by 8-bp inverted repeats (heavy
inal repeats (IRS and TRS). Each of the SV V ORFs are identified as
inframe cotranslational gene within ORF 33 and is homologous to the
3, and R4) are designated by black boxes. The putative origins of DNA
below the line indicate potential polyadenylation sites.
TABLE 1
SV V VZV Genome Comparison
Size (base pairs) G 1 C (%)
SV V VZVa SV V VZVa
Total genome 124,138 124,884 40.4 46.0
TRL/IRL 8 88.5 100.0 68.4
UL 104,104 104,836 38.3 44.3
Total L 104,120 105,013 38.3 44.3
TRS/IRS 7557 7319.5 65.0 59.0
US 4904 5232 39.1 42.8
Total S 20,018 19,871 58.6 54.7f a un
d term
tentiala Data derived from Davison and Scott (1986).
125SIMIAN VARICELLA VIRUS GENOMEthe SVV genome also includes terminal unpaired nucle-
otides (Clarke et al., 1995).
Compared to the 46% G 1 C content of VZV DNA, the
SVV genome has an overall 40.4% G 1 C content, similar
to the 40.8% G 1 C previously determined experimentally
by buoyant density analysis (Clarke et al., 1992). The SVV
L component has a slightly lower G 1 C content (38.3%)
than the VZV DNA L component (44.3%). Similar to VZV
DNA, the SVV DNA IRS and TRS have a relatively high G
1 C content (65.0%), while the US has a low G 1 C
content (39.1%).
SVV gene map
The map locations of the predicted SVV open reading
frames (ORFs) are shown in Fig. 1 and Table 2. SVV
ORFs were identified by methionine-initiated peptides of
at least 70 amino acids and by codon usage. The anal-
ysis was facilitated by comparison to the previously
published VZV gene map (Davison and Scott, 1986). A
total of 72 SVV ORFs were identified. This total includes
69 unique SVV genes, since three ORFs (69, 70, and 71)
are duplicated within the IRS and TRS. Of these 69 ORFs,
53 (77%) terminate near a consensus polyadenylation
site (Fig. 1, AATAAA or ATTAAA). Many of the SVV ORFs
that lack a polyadenylation site are included among
genes which have overlapping protein coding se-
quences. The overlapping ORFs were identified within
three regions of the SV V genome, including map units
0.35–0.40 (ORFs 26, 27, 28), map units 0.66–0.69 (ORFs
46, 47, 48, 49), and map units 0.79–0.82 (ORFs 57, 58 and
59, 60). Overlapping VZV genes are also confined within
these same general areas of the VZV genome (Davison
and Scott, 1986).
In general, the gene organization of the SVV and VZV
genomes is remarkably similar. With only a single excep-
tion (described below), each of the SVV ORFs has a
corresponding VZV homolog which shares amino acid
identity ranging from 75.4% (ORF 31, glycoprotein B) to
27.3% (ORF 1). For reasons of consistency, each of the
SVV ORFs is designated by a number corresponding to
the number of the VZV homolog.
The left terminus of the SVV and VZV genomes in-
cludes the most notable differences in gene organiza-
tion. First, SVV DNA does not include a homolog of the
VZV ORF 2, a gene of unknown function. Second, the SVV
genome encodes a gene, ORF A, which is not present in
the VZV genome. The 879-bp SVV ORF A is a truncated
homolog of ORF 4 with 42 and 49% amino acid identity to
the SVV and VZV ORF 4, respectively. The VZV ORF 4 is
a transcriptional activator of viral and cellular promoters
(Perera et al., 1994). The SVV left terminus also includes
a 342-bp ORF B, located adjacent to ORF 1. The ORF B is
homologous to the VZV ORF S/L, a recently identified
gene of unknown function (Mahalingam et al., 2000;
Kemble et al., 2000). A detailed analysis of the SVV leftterminus is reported elsewhere (Mahalingam et al.,
2000).
As with VZV and HSV-1, splicing of viral transcripts
appears to be an infrequent event in SVV gene expres-
sion. However, splicing involving SVV ORFs 42 and 45 as
protein coding exons is predicted (Fig. 1) based on anal-
ogy with VZV, HSV-1, and Epstein Barr virus (EBV) gene
homologs (Costa et al., 1984). The intron includes com-
plementary sequences to the opposite-strand ORFs 43
and 44. The HSV-1 homolog (UL 15) of the SVV and VZV
42/45 protein is a putative viral terminase and is one of
the six HSV-1 products required for DNA cleavage and
packaging (Yu and Weller, 1998). The significance of the
conservation of the splicing of this gene in alpha- and
gammaherpesviruses is not understood. Evidence for
RNA splicing was recently reported for the VZV strain
Oka ORF S/L transcript (Kemble et al., 2000). A 130 nt
intron was identified within the 39 untranslated region of
the ORF S/L mRNA. DNA sequence analysis suggests
that the homologous SVV ORF B transcript also includes
putative donor and acceptor splice sites and a 175 nu-
cleotide intron (nt 2698–2873) within the 39 untranslated
region.
Repetitive DNA
Tandem direct repeat sequences are commonly de-
tected within the genomes of herpesviruses (Davison
and Scott, 1986; McGeoch et al., 1988; Telford et al.,
1992). Four such reiterations were identified within the
SVV genome and are denoted as R1, R2, R3, and R4 (Fig.
1, Table 3). Three of these correspond to reiterations in
similar locations within the VZV genome.
The SVV DNA R1 reiteration occurs in a noncoding
region between ORFs 7 and 8. R1 consists of an A 1 T
rich (54%) 37 mer, which is tandemly repeated three
times. No such reiteration is found between ORFs 7 and
8 in the VZV genome. In contrast, the VZV R1, located
within the coding region of ORF 11, is a 305-bp sequence
including 15 or 18 bp direct repeat elements (Davison
and Scott, 1986). The SVV genome does not include a
corresponding repeat region within ORF 11.
The SVV R2, similar to the VZV R2, is located within the
coding region of ORF 14 (glycoprotein C). The 179-bp
SVV R2 includes an 83-bp G 1 C rich (66%) sequence
which is repeated twice, but is interrupted with a 13-bp
intervening sequence. The VZV R2 is a 42-bp sequence
which is repeated seven times in the VZV Dumas strain
(Davison and Scott, 1986).
The SVV and VZV R3 elements are located within the
coding frame of ORF 22. This is the longest (249 bp) and
most complex of the SVV reiterations and consists of
eight 12-bp repeats and seventeen 9-bp repeats. The
VZV R3 is a 9-bp sequence which is estimated to be
repeated as many as 100 times or more (Davison and
Scott, 1986). However, sequence analysis of this highly
126 GRAY ET AL.TABLE 2
SV V Open Reading Frames
ORF Start Stop Amino acids Size (kDa)a
VZV %
homologyb
VZV size
(aa)c
HSV-1
homolog Putative functiond/notes
A 1807 926 293 33.5 — — UL54 Truncated homolog of ORF 4
B 2327 2671 114 12.7 29.9 157–224 None Homolog of VZV ORF S/L
1 3036 2730 101 11.7 27.3 108 None Membrane protein
2 — — — — — 238 None SV V DNA does not include a
homolog of VZV ORF 2
3 3852 3301 183 19.7 63.7 179 UL55 Virion assembly
4 5533 4121 470 54.3 43.2 452 UL54 Transcriptional activator,
immediate early protein 2
5 6656 5643 337 42.0 59.3 340 UL53 Glycoprotein K
6 9906 6661 1081 123.3 37.7 1083 UL52 Component of DNA helicase-
primase complex
7 9917 10612 231 25.3 72.9 259 UL51 Virion phosphoprotein
8 12068 10881 395 44.9 38.2 396 UL50 DeoxyUTPase
9A 12037 12300 87 9.7 68.8 87 UL49A Glycoprotein N
9 12405 13310 301 33.2 59.4 302 UL49 Tegument protein
10 13537 14757 406 46.6 62.5 410 UL48 Transcriptional activator,
tegument protein
11 15076 17004 642 71.7 50.8 819 UL47 Tegument protein
12 17150 19117 655 73.4 60.1 661 UL46 Tegument protein
13 19243 20130 295 33.9 71.1 301 None Thymidylate synthetase
14 21841 20219 540 60.6 43.8 560 UL44 Glycoprotein C
15 23259 21994 421 47.3 36.2 406 UL43 Membrane protein
16 24493 23336 385 42.8 46.8 408 UL42 Associated with DNA polymerase
17 24719 26134 471 53.6 55.0 455 UL41 Host shutoff virion protein
18 27117 26182 311 36.2 72.6 306 UL40 Ribonucleotide reductase, small
subunit
19 29471 27120 783 88.2 68.7 775 UL39 Ribonucleotide reductase, large
subunit
20 31068 29665 467 52.9 60.5 483 UL38 Capsid protein
21 31243 34368 1041 116.8 52.0 1038 UL37 Tegument protein
22 34559 42520 2653 294.8 48.9 2763 UL36 Tegument protein
23 43870 43184 228 23.8 47.3 235 UL35 Capsid protein
24 44596 43952 214 23.9 61.5 269 UL34 Membrane phosphoprotein
25 45337 44876 153 17.4 45.2 156 UL33 Viral DNA cleavage/packaging
26 45249 46967 572 65.1 61.3 585 UL32 DNA cleavage/packaging
27 46894 47826 310 35.4 74.4 333 UL31 Nuclear phosphoprotein
28 51268 47750 1172 113.2 65.7 1194 UL30 DNA polymerase
29 51454 55038 1194 132.0 71.9 1204 UL29 Single-stranded DNA binding
protein
30 55125 57407 760 86.5 61.3 770 UL28 Viral DNA cleavage/packaging
31 57266 60016 916 104.0 75.4 868 UL27 Glycoprotein B
32 60152 60559 135 15.0 49.6 143 None Phosphoprotein
33 62412 60646 588 65.1 64.4 605 UL26 Protease, capsid assembly
protein
34 64182 62443 579 65.7 61.1 579 UL25 Viral DNA cleavage/packaging
35 64992 64246 248 28.7 49.7 258 UL24 Membrane protein
36 65018 66031 337 37.9 52.3 341 UL23 Thymidine kinase
37 66204 68762 852 96.8 55.5 841 UL22 Glycoprotein H
38 70414 68813 533 59.8 60.3 541 UL21 Virion protein
39 70693 71364 223 25.4 53.1 240 UL20 Envelope protein, viral egress
40 71553 75731 1392 155.9 73.3 1396 UL19 Major capsid protein
41 75826 76773 315 34.3 70.5 316 UL18 Capsid protein
42/45 78005 76821 744 84.1 67.7 747 UL15 Spliced producte
Viral terminase
82424 81372
43 78037 80073 678 75.9 47.3 676 UL17 Viral DNA cleavage/packaging
44 80217 81299 360 39.8 69.3 363 UL16 Virion protein
46 82536 83135 199 22.5 58.2 199 UL14 Tegument protein
47 82988 84511 507 57.7 64.8 510 UL13 Protein kinase
48 84475 86004 509 57.8 56.2 551 UL12 Deoxyribonuclease
, 1996;
127SIMIAN VARICELLA VIRUS GENOMErepetitive structure in VZV DNA is difficult due to its
unstable nature when cloned into Escherichia coli.
The SVV and VZV R4 reiterations are included within a
noncoding region between ORFs 62 and 63 of the IRS
and between ORFs 70 and 71 of the TRS (Fig. 1). The SVV
R4 is a 119-bp G 1 C rich (81%) element consisting of a
16-bp sequence which is tandemly repeated seven times
plus a 7-bp partial repeat. The SVV R4 shares homology
to the VZV R4 that consists of a 27-bp element which is
repeated four times.
The VZV genome has an additional R5 direct repeat
sequence located within the 1400-bp noncoding region
between ORFs 60 and 61 (Davison and Scott, 1986;
Hondo and Yogo, 1988). The VZV R5 consists of an 88-bp
element and an adjacent 24-bp element which together
constitute a repeat unit whose copy number varies from
one to three in various VZV strains. The SVV genome
also includes a long noncoding region (1180 bp) between
ORFs 60 and 61. Repeat elements were not identified
TABLE 2
ORF Start Stop Amino acids Size (kDa)a
V
ho
49 86004 86252 82 9.2
50 87656 86337 439 49.5
51 87665 90115 816 92.8
52 90232 92529 765 86.0
53 93512 92598 304 34.5
54 95610 93403 735 83.5
55 95645 98254 869 97.8
56 98326 98889 187 21.3
57 99137 98919 72 8.2
58 99745 99134 203 22.9
59 100661 99759 300 34.6
60 101092 100565 175 20.2
61 103781 102270 503 54.1
62 108458 104619 1279 136.8
63 109844 110629 261 29.3
64 110851 111414 187 21.1
65 111948 111715 77 9.0
66 112388 113425 345 38.9
67 113656 114717 353 40.5
68 114937 116751 604 67.6
69 117408 116845 187 21.1
70 118415 117629 261 29.3
71 119801 123640 1279 136.8
a Predicted size based on amino acid sequence.
b Based on % amino acid identity with the homologous VZV protein.
c Derived from Davison and Scott (1986).
d Based on known VZV function or function of HSV-1 homolog (Arvin
e Predicted spliced gene including ORF 42 and 45 exons.within this region of the SVV genome. However, since
repeat elements may vary among SVV isolates, furtheranalysis of additional SVV isolates may reveal a R5
element.
The VZV R1, R2, R3, R4, and R5 are variable in size
among VZV isolates, causing some diversity in the
total size of VZV DNA ranging from 124 to 126 kb. For
example, the 42-bp R2 sequence is repeated seven
times in VZV strain Dumas, but only three times in VZV
strain Oka (Davison and Scott, 1986; Kinchington et al.,
1986). In contrast, analysis of the genomes of four
epidemiologically distinct SV V isolates indicates that
the SV V 83-bp R2 does not vary in number and is only
repeated twice (data not shown). The SV V R1, R3, and
R4 have not yet been analyzed for diversity among SV V
isolates.
The function, if any, of these tandem reiterations in
SVV DNA and the genomes of other herpesvirus ge-
nomes is unknown. They have been speculated to be
“parasitic” sequences which have been incorporated,
possibly by recombination, into the viral genomes in
tinued
b
VZV size
(aa)c
HSV-1
homolog Putative functiond/notes
81 UL11 Myristylated virion protein
435 UL10 Glycoprotein M
835 UL9 Origin binding protein
771 UL8 Component of DNA helicase-
primase complex
331 UL7 Gamma-1 protein
769 UL6 Viral DNA cleavage/packaging
881 UL5 Component of DNA helicase-
primase complex
244 UL4 Gamma-2 protein
71 None Nonessential VZV protein
221 UL3 Phosphoprotein
305 UL2 Uracil DNA glycosylase
159 UL1 Glycoprotein L
467 RL2 Transcriptional activator,
repressor, immediate early
protein 1
1310 RS1 Transcriptional activator,
immediate early protein 3
278 US1 Transcriptional activator,
immediate early protein 4
180 US10 Tegument phosphoprotein
102 US9 Tegument phosphoprotein
393 US3 Protein kinase
354 US7 Glycoprotein I
623 US8 Glycoprotein E
180 US10 Duplicate of orf 64
278 US1 Duplicate of orf 63
1310 ICP4 Duplicate of orf 62
Harper et al., 1998; Subak-Sharpe and Dargan, 1998).—Con
ZV %
mology
50.0
57.5
53.7
50.4
56.6
59.5
75.2
37.7
39.5
42.0
55.4
43.5
42.8
58
52
56
49
66
37
47
56
52
58locations where they do not cause a deleterious effect
and thus are conserved (Davison and Scott, 1986).
e.
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Genetic analysis of viral genomes provides an un-
derstanding of the evolutionary relationships among
herpesviruses (McGeoch et al., 1995). The striking
similarity in genetic content of the SV V and VZV ge-
nomes indicates a common evolutionary origin and
divergence from a common ancestral varicella virus.
Further phylogenetic comparison of the SV V and VZV
DNA sequences will permit the derivation of a time
scale for the divergence of SV V and VZV and provide
an excellent model system for investigation of alpha-
herpesvirus evolution.
The genetic relatedness of SVV and VZV is correlated
to similarities in the biological properties of the viruses,
including viral morphology, replication, and pathogene-
sis. However, VZV replicates most efficiently in cells of
human origin and causes disease in humans, but not in
monkeys. Conversely, SV V replicates optimally in cells of
nonhuman primate origin and is not associated with
disease in humans. Genetic analysis of the differences
between the SVV and VZV genomes may reveal the
molecular basis for the species specificity of these vi-
ruses.
The complete DNA sequence of the SVV genome
provides a blueprint for investigating the function of SVV
genes and their roles in viral replication, pathogenesis,
and latency. The information will be important for the
development of diagnostic assays and antiviral strate-
gies to control simian varicella epizootics which occur in
facilities housing nonhuman primates. In addition, this
study provides further support for simian varicella as a
model to investigate the molecular basis of VZV patho-
T
SV V Genome Ta
Repeat
Genome
location Repeat sequenc
R1 between
orfs 7/8
(AAACAAAGCATTTCCACAACTGCTGGG
R2 orf 14 (GCCTGGGGGGTGGGCGCTTGATGTAA
GGTGCGGTGCTGGACTGTTGATGCG
R3 orf 22 Repeat A (TCTCAGCCCCCC)
Repeat B (TCTCAGCCC)
Repeat C (TCTCAGGCC)
Reiterated region 5 AAAAABBBBABCB
R4 between
orfs 62/63
orfs 70/71
(AGAGGGGGGACGGGGG)
a Initial A of the first R1 repeat is not present.
b The two R2 repeats are separated by a 13-bp intervening sequenc
c The final repeat of R4 is AGAGGGG.genesis and the development and evaluation of VZV
antiviral agents and vaccines.MATERIALS AND METHODS
Virus culture and isolation of SVV DNA
The Delta herpesvirus strain of SVV was originally
isolated from an infected patas monkey (Erythrocebus
patas) at the Tulane Regional Primate Center in Coving-
ton, LA (Ayres, 1971). SVV was propagated in African
green monkey kidney (BSC-1) cells in Eagle’s minimal
essential medium (EMEM) supplemented with penicillin
(5000 U/ml), streptomycin (5000 U/ml), and 5% newborn
calf serum. The virus was passaged by cocultivation of
infected and uninfected cells at a ratio of 1:4, respec-
tively. SVV DNA was purified from viral nucleocapsids
derived from infected BSC-1 cells (Gray et al., 1992).
DNA sequencing
SVV DNA BamHI and EcoRI restriction endonuclease
(RE) fragments making up the entire viral genome were
cloned into plasmid vectors (Gray et al., 1992). The Ge-
nome Priming System (New England Biolabs, Inc.) was
used to generate subclones and DNA sequencing tem-
plates with random interspersed primer binding sites.
Both strands of each RE fragment were sequenced. DNA
between adjacent nonoverlapping RE fragments was
amplified by PCR using SVV genomic DNA as template
and oligonucleotide primers which were synthesized
based on the DNA sequence at the RE fragment termini.
Dideoxy chain termination sequencing reactions were
performed using oligonucleotide primers, AmpliTaq DNA
polymerase, and the ABI Prism BigDye or dRhodamine
terminator cycle sequencing ready reaction kit (Perkin–
Elmer Applied Biosystems). Reaction products were an-
alyzed using a Perkin–Elmer Applied Biosystems Prism
Repeat Regions
Copy
no.
Element
size (nt)
Partial
size (nt)
Total
size (nt)
ATGGG)a 3 37 0 110
GTGCGGGATCG
GGCGCGGGATC)
2 83 0 179b
8 12 0 249
15 9
2 9
BBBBBBB
7 16 7c 119ABLE 3
ndem
e
TTTAC
TTGTG
ACTGC
BCAAB377 DNA fluorescence sequencer.
The DNA sequence of the left and right termini of the
t
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G
G
H
H
K
K
M
M
M
M
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129SIMIAN VARICELLA VIRUS GENOMESVV genome was previously determined (Clarke et al.,
1995; Mahalingam et al., 2000). Briefly, SVV DNA con-
aining the left and right termini was amplified by PCR
sing primers located near the ends of the viral genome.
equence analysis of the resulting PCR product along
ith sequence analysis of the SVV IRL/IRS junction (Gray
t al., 1995) was used to define the DNA sequence of the
nds of the SVV genome.
NA sequence analysis
The DNA sequence data were assembled and ana-
yzed using the Sequence Analysis Software Package of
he Genetics Computer Group (GCG), University of Wis-
onsin (Devereux et al., 1984). Overlapping nucleotide
sequences of both DNA strands were assembled into
the final sequence using the Gel Assemble program
based on the method of Staden (Staden, 1980). Protein
coding regions were determined by using the Frames
and Testcode programs (Fickett, 1982). The Codon Pref-
erence and Codon Frequency programs were used to
analyze codon usage and confirm ORFs (Gribskov et al.,
1984). Amino acid sequence homologies were deter-
mined using the Bestfit program, which employs the
local homology algorithm of Smith and Waterman (1981).
The Motifs program was used to search for sequence
motifs within protein sequences for patterns defined in
the PROSITE Dictionary of Protein Sites and Patterns
(Bairoch, 1991). The SV V DNA sequence is available in
the GenBank data library under the Accession No.
AF275348.
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